The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.

McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K. · 2007

Read The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. by McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2092390.txt.

Introduction

McClintock and colleagues reported in 2007 that a protein behind a rapid-ageing disease also marks normal ageing in skin. Hutchinson-Gilford progeria makes children age fast and die early, often from stroke or heart disease. Most cases carry a mutation that produces a faulty lamin A protein, called progerin. The team screened 150 skin biopsies from healthy people aged from newborn to 97 years.

The same splicing event occurred at low level in normal skin at all ages. Progerin messenger RNA stayed low, but the protein built up with age. It appeared in some skin fibroblasts and a few surface skin cells. Positive cells sat near the basement membrane in young adults. In elderly skin they spread deeper and grew more numerous. The authors call progerin a biomarker of normal cellular ageing.

Catalog record

CREATORMcClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC0 1.0 Universal
RIGHTSCC0
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2092390

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Mutant Form of Lamin A that Causes Hutchinson-Gilford Progeria Is a Biomarker of Cellular Aging in Human Skin By Dayle McClintock, Desiree Ratner, Meepa Lokuge, David M Owens, Leslie B Gordon, Francis S Collins, Karima Djabali, Alfred Lewin Published in: PLoS ONE DOI: 10.1371/journal.pone.0001269 ABSTRACT Abstract Hutchinson-Gilford progeria syndrome (HGPS, OMIM 176670) is a rare disorder characterized by accelerated aging and early death, frequently from stroke or coronary artery disease. 90% of HGPS cases carry the LMNA G608G (GGC>GGT) mutation within exon 11 of LMNA, activating a splice donor site that results in production of a dominant negative form of lamin A protein, denoted progerin. Screening 150 skin biopsies from unaffected individuals (newborn to 97 years) showed that a similar splicing event occurs in vivo at a low level in the skin at all ages. While progerin mRNA remains low, the protein accumulates in the skin with age in a subset of dermal fibroblasts and in a few terminally differentiated keratinocytes. Progerin-positive fibroblasts localize near the basement membrane and in the papillary dermis of young adult skin; however, their numbers increase and their distribution reaches the deep reticular dermis in elderly skin. Our findings demonstrate that progerin expression is a biomarker of normal cellular aging and may potentially be linked to terminal differentiation and senescence in elderly individuals. INTRODUCTION Lamins of the A- and B-type are intermediate filament proteins that constitute major components of the nuclear lamina, a filamentous meshwork forming an interface between the inner nuclear membrane and the chromatin [1]. Lamins A and C, the major isoforms of A-type lamins, are expressed in all differentiated vertebrate cells [2] and are translated from alternatively spliced transcripts of the LMNA gene. In contrast to the single LMNA gene, there are two B-type lamin genes: LMNB1 gene encodes lamin B1 protein [3], [4], while LMNB2 encodes two protein products by alternative splicing: lamin B2 and lamin B3, [5], [6]. The B-type lamins are expressed throughout development, and one or more B-type lamins are present in all cell types [7]–[9] Lamins are located at the nuclear lamina and throughout the nucleoplasm [10], [11], where they seem to play fundamental roles in the shape, integrity and function of the nucleus and in DNA replication and RNA transcription [12]. Lamin A and lamin B are modified at their carboxyl-terminal –CAAX box through a series of post-translational modifications. The modifications include, successively, farnesylation of the cysteine in the C-terminal CaaX motif (C, cysteine; a, aliphatic; X, any amino acid), followed by a proteolytic cleavage of the aaX-terminal tripeptide, and by methylation of the farnesylated cysteine [13]. While B-type lamins remain permanently farnesylated, prelamin A (the precursor of mature lamin A) undergoes a second cleavage of the remaining 15 C-terminal residues (aa 647–661) to give rise to the mature lamin A, therefore losing its farnesyl modification [13], [14]. The enzyme responsible for these sequential proteolytic cleavages is the zinc metalloproteinase ZMSPTE24, for which lamin A is the only known substrate in mammals [15]. Mutations in LMNA are implicated in 12 distinct disorders, commonly referred to as laminopathies, and involve different tissues, including muscle, peripheral nerve, adipose, bone and skin tissue. These disorders exhibit distinct clinical phenotypes associated with features such as myopathy, cardiomyopathy, lipodystrophy, neuropathy and premature aging [16]–[18]. The two best-known examples of accelerated aging syndrome in humans are Hutchinson-Gilford progeria syndrome (HGPS, ‘Progeria of childhood’) and Werner syndrome (WS, ‘Progeria of the adult’). Whereas most cases of WS have been caused by mutations in WRN helicase [19], a subset of WS patients do not show mutations at the WRN locus (atypical WS), but show heterozygous amino acid substitutions in the heptad repeat region of lamin A [20]–[22]. Hutchinson Gilford progeria syndrome (HGPS, OMIM 176670) is a rare sporadic disorder with an incidence of 1 per 4–8 million live births, consisting of a premature aging phenotype with rapid growth deceleration in childhood [18]. Appearance at birth and birth weight are usually normal, but growth is typically slowed by the age of one year [23]. The phenotypic appearance consists of the following: short stature, sculpted nose, alopecia, prominent scalp veins, loss of subcutaneous fat, and dystrophic nails. In addition, HGPS patients show skeletal abnormalities that may reflect deficient osteogenesis, principally in the extremities, mandibular and cranial dysplasia with disorganized growth, deformations in dentition and severe osteolysis [24] [25]. The common causes of death in HGPS subjects during the second decade of life are chronic conditions most common in elderly people, especially coronary artery disease and stroke due to widespread arteriosclerosis [26]. Nearly 90% of the subjects affected with HGPS carry a de novo G608G (GGC>GGT) mutation within exon 11 of LMNA, [22], [27], [28]. This single nucleotide change activates a cryptic splice donor site, which results in a deletion of the 3′ terminal 150 nucleotides of exon 11 of the mRNA, causing a 50 amino acid internal truncation near the carboxyl-terminus of prelamin A [28]. The truncated lamin A, referred to as progerin, lacks amino acids 607 to 656 of prelamin A but retains the CAAX box [22], [27], [28]. Because the endoproteolytic cleavage site for ZMPSTE24 is lost in the mutant protein, progerin remains permanently farnesylated causing its tight association with the nuclear envelope and producing numerous nuclear envelope abnormalities [29], [30]. This modification also appears to affect the dynamic state of progerin within the lamina [31], [32]. Cells derived from HGPS individuals and subjects with pathologies resembling HGPS, such as atypical progeria Werner Syndrome (WS), Restrictive Dermopathy (RD), and Mandibular Dysplasia (MAD), appear to share a common feature: accumulation of prelamin A, either as full-length prelamin A protein or various truncated forms of prelamin A [14]. In all of these diseases, the prelamin A or mutant prelamin A remains farnesylated and accumulates within the nuclear compartment as cellular generation increases [29], [30], [33]. The persistence of the farnesylated form appears to be the key element responsible for severe nuclear abnormalities and defects in heterochromatin organization, mitosis, DNA replication, transcription and repair [34]–[37]. Recently, rare fibroblasts cultured from elderly individuals were found to exhibit nuclear phenotypes identical to those of HGPS cells [38]. Intriguingly, while those cells expressed progerin mRNA transcripts at barely detectable levels [38], long-term cultures contained a few abnormal nuclei that were clearly positive with anti-progerin specific antibody [39]. These observations indicate that progerin is also expressed in normal cells. Presumably, the cryptic splice donor site in exon 11 of LMNA is activated by the HGPS mutation, but the normal sequence is able to function in a similar fashion under some circumstances, at least in long-term culture. To further address the biological relevance of progerin expression in unaffected individuals and its relationship to normal aging, we followed the spatiotemporal expression pattern of progerin in human skin at all ages. Herein, we provide new evidence indicating that progerin is expressed and accumulates in vivo during normal aging. RESULTS In vivo detection of progerin in unaffected individuals Using the human skin as our model system, we investigated whether progerin is expressed in the skin of unaffected individuals. 150 skin biopsies from newborn foreskins and from unaffected individuals, including equal numbers of females and males ranging in age from 22 to 97 years were

Read the complete text